Hua Pan, PhD

Research Program Solid Tumor Therapeutics
Hua Pan

Researcher Background

Primary Academic Title

Associate Professor of Medicine, Division of Rheumatology, WashU Medicine

Training

  • 2007 - 2010: Postdoctoral Research Associate, Cardiology, WashU Medicine, St. Louis, MO

Education

  • 2000: Master of Medicine, Biomedicine, Huazhong University of Science and Technology, Wuhan, China
  • 2004: ME, Biomedical Engineering, Case Western Reserve University, Cleveland, OH
  • 2007: PhD, Biomedical Engineering, WashU Medicine, St. Louis, MO
  • 2014: MBA, General Management/Entrepreneurship, Washington University, St. Louis, MO

Research & Selected Publications

Research Interest

Development of new anti-cancer therapeutic platforms, as well as mechanistic understanding and prevention of cancer treatment-induced toxicities that can limit continuation of effective therapy and result in undertreatment.

Research Publications

Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice.
Authors:

Zhou Q, Harding JC, Fan P, one or more additional authors omitted Pan H

Journal & Year:

Nanomaterials (Basel) • 2024

ZBTB46 coordinates angiogenesis and immunity to control tumor outcome.
Authors:

Kabir AU, Zeng C, Subramanian M, one or more additional authors omitted Pan H, one or more additional authors omitted Choi K

Journal & Year:

Nat Immunol • 2024